• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

    5/5/25 2:53:25 PM ET
    $CLB
    Oilfield Services/Equipment
    Energy
    Get the next $CLB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Tattoli Mark Damian

    (Last) (First) (Middle)
    6316 WINDFERN ROAD

    (Street)
    HOUSTON TX 77040

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Core Laboratories Inc. /DE/ [ CLB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    SVP, Gen Counsel & Secretary
    3. Date of Earliest Transaction (Month/Day/Year)
    05/01/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/01/2025 F 99 D $11.68 16,143.621 D
    Common Stock 05/01/2025 M 250 A $0 16,242.621 D
    Common Stock 05/01/2025 F 79 D $11.68 15,992.621 D
    Common Stock 05/01/2025 M 200 A $0 16,071.621 D
    Common Stock 20 I Custodial account
    Common Stock 1,694.842 I 401 (k) Plan
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Shares (1) 05/01/2025 M 250 (1) (1) Common Stock 250 $0 2,400(2) D
    Restricted Shares (1) 05/01/2025 M 200 (1) (1) Common Stock 200 $0 2,650(2) D
    Explanation of Responses:
    1. The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount specified in the award agreement, provided the reporting person remains in continuous service on each such vesting date.
    2. Multiple restricted share grants are included in this total.
    /s/ Mark D. Tattoli 05/05/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLB

    DatePrice TargetRatingAnalyst
    3/12/2025$15.00 → $16.00Sell → Neutral
    Citigroup
    6/30/2023$22.00 → $21.00Neutral → Sell
    Citigroup
    4/18/2023$21.50Neutral → Underperform
    BofA Securities
    1/9/2023Underperform → Neutral
    BofA Securities
    10/7/2022$24.00 → $17.00Sell → Neutral
    Citigroup
    9/26/2022$20.00Equal-Weight → Underweight
    Morgan Stanley
    4/18/2022$19.50 → $21.30Neutral → Underweight
    Piper Sandler
    1/18/2022$32.00 → $30.00Equal-Weight
    Morgan Stanley
    More analyst ratings

    $CLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CORE LABORATORIES ANNOUNCES OPENING OF UNCONVENTIONAL CORE ANALYSIS LABORATORY IN SAUDI ARABIA

      HOUSTON, May 7, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") is pleased to announce the opening of its new Unconventional Core Analysis Laboratory in Dammam, Kingdom of Saudi Arabia. This state-of-the-art facility, developed in collaboration with Core's long-time partner, Abdulla Fouad Group, underscores the Company's commitment to advancing reservoir evaluation technologies in the Middle East. The Company's new analytical laboratory is equipped with advanced proprietary instrumentation designed to provide comprehensive core and fluid analysis services tailored to unconventional reservoirs. By bringing Core Lab's cutting-edge technologies t

      5/7/25 12:53:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Core Labs upgraded by Citigroup with a new price target

      Citigroup upgraded Core Labs from Sell to Neutral and set a new price target of $16.00 from $15.00 previously

      3/12/25 7:22:24 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by Citigroup with a new price target

      Citigroup downgraded Core Labs from Neutral to Sell and set a new price target of $21.00 from $22.00 previously

      6/30/23 7:19:53 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Labs downgraded by BofA Securities with a new price target

      BofA Securities downgraded Core Labs from Neutral to Underperform and set a new price target of $21.50

      4/18/23 9:05:50 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Core Laboratories Inc. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      6/12/23 4:02:30 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 4:08:12 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form SC 13G/A filed by Core Laboratories N.V. (Amendment)

      SC 13G/A - CORE LABORATORIES N V (0001000229) (Subject)

      2/14/23 9:10:51 AM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    Financials

    Live finance-specific insights

    See more

    $CLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CORE LAB REPORTS FIRST QUARTER 2025 RESULTS

      REVENUE OF $123.6 MILLION, DOWN 4% SEQUENTIALLY AND 5% YEAR-OVER-YEAROPERATING INCOME OF $4.4 MILLION; EX-ITEMS, $11.8 MILLION, DOWN 25% SEQUENTIALLY AND 21% YEAR-OVER-YEAROPERATING MARGINS, EX-ITEMS, OF 10% GAAP EPS OF $0.00; EX-ITEMS, $0.14, DOWN 35% SEQUENTIALLY, AND 25% YEAR-OVER-YEARFREE CASH FLOW OF $3.9 MILLION, UP OVER 50% YEAR-OVER-YEAR NET DEBT REDUCED BY $4.9 MILLION; DEBT LEVERAGE RATIO REMAINS AT 1.31 COMPANY REPURCHASED 131,598 SHARES OF COMMON STOCK, A VALUE OF $2.0 MILLION COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDEND HOUSTON, April 23, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported first quarter 2025 revenue of $123,6

      4/23/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LABORATORIES ANNOUNCES TIMING OF FIRST QUARTER 2025 EARNINGS RELEASE AND CONFERENCE CALL

      HOUSTON, March 24, 2025 /PRNewswire/ -- Core Laboratories (NYSE: "CLB") will host its first quarter 2025 conference call for investors and analysts at 7:30 a.m. CDT / 8:30 a.m. EST on April 24, 2025. Larry Bruno, Chairman and CEO, Chris Hill, CFO, and Gwen Gresham, SVP Corporate Development and Investor Relations, will discuss financial and operational results. An earnings press release will be issued after market close on April 23, 2025, and may be accessed through the Company's website at www.corelab.com. To register for the listen-only webcast, log on to www.corelab.com at least fifteen minutes prior to the start of the call. For those not available to listen to the live webcast, a replay

      3/24/25 4:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2024 RESULTS

      FOURTH QUARTER REVENUE OF $129.2 MILLION, DOWN 4% SEQUENTIALLY AND UP SLIGHTLY YEAR-OVER-YEARFOURTH QUARTER OPERATING INCOME OF $14.2 MILLION; EX-ITEMS, $15.7 MILLION, DOWN 14% SEQUENTIALLY, UP 4% YEAR-OVER-YEAR FOURTH QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% FOURTH QUARTER GAAP EPS OF $0.15; EX-ITEMS, $0.22, DOWN 12% SEQUENTIALLY, UP 16% YEAR-OVER-YEAR FOURTH QUARTER FREE CASH FLOW OF $16.2 MILLION, UP OVER 50% SEQUENTIALLY DEBT LEVERAGE RATIO REDUCED TO 1.31, AND NET DEBT REDUCED BY $11.7 MILLION COMPANY REPURCHASED 264,982 SHARES OF COMMON STOCK, A VALUE OF $4.9 MILLION, DURING THE FOURTH QUARTER COMPANY ANNOUNCES Q1 2025 QUARTERLY DIVIDENDFULL YEAR REVENUE OF $523.8 MILLION, UP 3%FULL

      1/29/25 5:15:00 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • CAO & Treasurer Teo Sow Hang covered exercise/tax liability with 79 shares and converted options into 175 shares (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:55:21 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SVP, Gen Counsel & Secretary Tattoli Mark Damian covered exercise/tax liability with 178 shares and converted options into 450 shares, decreasing direct ownership by 1% to 16,072 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      5/5/25 2:53:25 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Director Temeng Kwaku converted options into 9,317 shares, increasing direct ownership by 57% to 25,528 units (SEC Form 4)

      4 - Core Laboratories Inc. /DE/ (0001958086) (Issuer)

      4/2/25 2:40:47 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy

    $CLB
    SEC Filings

    See more
    • SEC Form 10-Q filed by Core Laboratories Inc.

      10-Q - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/25/25 6:36:23 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • Core Laboratories Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      4/23/25 4:41:18 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy
    • SEC Form DEFA14A filed by Core Laboratories Inc.

      DEFA14A - Core Laboratories Inc. /DE/ (0001958086) (Filer)

      3/31/25 4:59:20 PM ET
      $CLB
      Oilfield Services/Equipment
      Energy